Table 1.
Linkage-to-care and treatment rate of chronic hepatitis B
| Index | 2018 |
2019 |
2020 |
Average (2018–2020) | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total | Male | Female | Total | Male | Female | Total | Male | Female | |||
| Estimated CHB population, n | 1,183,279 | 714,900 | 468,379 | 1,051,155 | 575,622 | 475,533 | 1,289,549 | 754,470 | 535,079 | 1,174,661 | |
| Prevalence of CHB, % | 2.4 | 2.9 | 1.9 | 2.0 | 2.2 | 1.8 | 2.4 | 2.7 | 2.0 | 2.3 | |
| Linkage-to-care population, n | 444,933 | 265,400 | 179,533 | 466,974 | 276,050 | 190,924 | 466,497 | 275,409 | 191,088 | 459,468 | |
| Linkage-to-care rate, % | 37.6 | 37.1 | 38.3 | 44.4 | 48.0 | 40.1 | 36.2 | 36.5 | 35.7 | 39.4 | |
| Estimated CHB population to be treated, n | 384,049 | 238,507 | 145,543 | 355,424 | 206,191 | 149,233 | 416,966 | 252,093 | 164,873 | 385,480 | |
| Estimated CHB population to be treated, % | 32.5 | 33.4 | 31.1 | 33.8 | 35.8 | 31.4 | 32.3 | 33.4 | 30.8 | 32.9 | |
| Treated CHB population, n | 246,473 | 160,839 | 85,634 | 260,347 | 168,423 | 91,924 | 268,917 | 172,952 | 95,965 | 258,579 | |
| Treatment rate*, % | 64.2 | 67.4 | 58.8 | 73.2 | 81.7 | 61.6 | 64.5 | 68.6 | 58.2 | 67.3 | |
CHB, chronic hepatitis B.
*
Treatment rate is calculated as the proportion of patients with antiviral claim data among the estimated CHB population to be treated, not among the estimated CHB population.